The success of G12C inhibitors fundamentally changed the perception of KRAS from an "undruggable" target to a clinically actionable oncogenic driver and established the foundation for subsequent KRAS-targeted drug development
Awesome product Valeur sur Great work, keep it up
ALDH2 activity in mitochondrial extracts was measured using XTT (Polyscience Inc, Warrington, PA, USA) with acetaldehyde as substrate according to a previously described assay [37]
Intranasal delivery of MSC-EVs in TBI animal models has been shown to promote neurofunctional recovery, suppress NLRP3 inflammasome activation, inhibit p38 MAPK signalling, and prevent microglial polarization toward the pro-inflammatory M1 phenotype, collectively improving behavioural and cognitive outcomes [393]
Oral formulations are designed to survive the stomach acid and are better suited for addressing systemic inflammation and gastrointestinal issues like ulcers or inflammatory bowel disease